Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis.

PubWeight™: 2.70‹?› | Rank: Top 1%

🔗 View Article (PMC 3660784)

Published in Br J Dermatol on April 01, 2013

Authors

T Dirschka1, P Radny, R Dominicus, H Mensing, H Brüning, L Jenne, L Karl, M Sebastian, C Oster-Schmidt, W Klövekorn, U Reinhold, M Tanner, D Gröne, M Deichmann, M Simon, F Hübinger, G Hofbauer, G Krähn-Senftleben, F Borrosch, K Reich, C Berking, P Wolf, P Lehmann, M Moers-Carpi, H Hönigsmann, K Wernicke-Panten, S Hahn, G Pabst, D Voss, M Foguet, B Schmitz, H Lübbert, R-M Szeimies, AK-CT002 Study Group, AK-CT003 Study Group

Author Affiliations

1: Private Dermatological Practice Centre, Wuppertal, Germany.

Associated clinical trials:

This Study Aims to Evaluate the Safety and Efficacy of BF-200 ALA for the Treatment of Actinic Keratosis With Photodynamic Therapy (PDT) | NCT02799069

Articles cited by this

Ingenol mebutate gel for actinic keratosis. N Engl J Med (2012) 2.75

Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol (2007) 2.03

A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck. J Am Acad Dermatol (1991) 1.75

Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo. Br J Dermatol (2011) 1.75

Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase III study. Br J Dermatol (2010) 1.65

Development of a treatment algorithm for actinic keratoses: a European Consensus. Eur J Dermatol (2008) 1.48

Epidemiology of solar keratoses. Br J Dermatol (1994) 1.42

Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification. Br J Dermatol (2007) 1.21

Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up. Br J Dermatol (2006) 1.19

The prevalence and determinants of solar keratoses at a subtropical latitude (Queensland, Australia). Br J Dermatol (1998) 1.16

Long-term follow-up of photodynamic therapy with a self-adhesive 5-aminolaevulinic acid patch: 12 months data. Br J Dermatol (2009) 1.01

Fluorescence induction of protoporphyrin IX by a new 5-aminolevulinic acid nanoemulsion used for photodynamic therapy in a full-thickness ex vivo skin model. Exp Dermatol (2010) 0.96

Short incubation with methyl aminolevulinate for photodynamic therapy of actinic keratoses. J Eur Acad Dermatol Venereol (2009) 0.95

Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies. Br J Dermatol (2009) 0.94

Articles by these authors

The sequence of the human genome. Science (2001) 101.55

Essential Bacillus subtilis genes. Proc Natl Acad Sci U S A (2003) 14.01

Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector. Proc Natl Acad Sci U S A (1992) 13.77

Flagellar rotation and the mechanism of bacterial motility. Nature (1974) 10.38

Five intermediate complexes in transcription initiation by RNA polymerase II. Cell (1989) 9.22

Effect of large-scale social marketing of insecticide-treated nets on child survival in rural Tanzania. Lancet (2001) 8.43

Crystal structure of a yeast TBP/TATA-box complex. Nature (1993) 7.95

In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet (1995) 6.60

Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci U S A (1996) 5.93

Analysis of the nucleotide sequence of an invertible controlling element. Proc Natl Acad Sci U S A (1980) 5.92

Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci U S A (1994) 5.74

Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants. Lancet (1997) 5.59

Ageing, fitness and neurocognitive function. Nature (1999) 5.58

An operator at -280 base pairs that is required for repression of araBAD operon promoter: addition of DNA helical turns between the operator and promoter cyclically hinders repression. Proc Natl Acad Sci U S A (1984) 5.42

A second set of loxP marker cassettes for Cre-mediated multiple gene knockouts in budding yeast. Nucleic Acids Res (2002) 5.38

Genetic analysis of flagellar mutants in Escherichia coli. J Bacteriol (1973) 4.98

Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial. Lancet (2001) 4.86

Identification of polypeptides necessary for chemotaxis in Escherichia coli. J Bacteriol (1977) 4.84

Characterization of Escherichia coli flagellar mutants that are insensitive to catabolite repression. J Bacteriol (1974) 4.84

Each of three "TATA elements" specifies a subset of the transcription initiation sites at the CYC-1 promoter of Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1985) 4.69

Regulation of lateral flagella gene transcription in Vibrio parahaemolyticus. J Bacteriol (1986) 4.52

Chemotaxis in Escherichia coli: methylation of che gene products. Proc Natl Acad Sci U S A (1977) 4.34

Recombinational switch for gene expression. Science (1977) 4.31

Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosomes Cancer (1998) 4.22

Impact on malaria morbidity of a programme supplying insecticide treated nets in children aged under 2 years in Tanzania: community cross sectional study. BMJ (2001) 4.14

Phase variation: genetic analysis of switching mutants. Cell (1980) 4.05

Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res (1997) 4.02

Operon controlling motility and chemotoxis in E. coli. Nature (1976) 3.95

Structure and function of the Saccharomyces cerevisiae CDC2 gene encoding the large subunit of DNA polymerase III. EMBO J (1989) 3.93

Function of a yeast TATA element-binding protein in a mammalian transcription system. Nature (1988) 3.91

African children with malaria in an area of intense Plasmodium falciparum transmission: features on admission to the hospital and risk factors for death. Am J Trop Med Hyg (1999) 3.87

How snapping shrimp snap: through cavitating bubbles. Science (2000) 3.67

A transcription reinitiation intermediate that is stabilized by activator. Nature (2000) 3.65

Diagnostic accuracy and case management of clinical malaria in the primary health services of a rural area in south-eastern Tanzania. Trop Med Int Health (2001) 3.62

Absence of seasonal variation in malaria parasitaemia in an area of intense seasonal transmission. Acta Trop (1993) 3.59

European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol (2009) 3.56

Genetic analysis of bacteriophage Mu-induced flagellar mutants in Escherichia coli. J Bacteriol (1973) 3.55

Measuring gene expression with light. Science (1985) 3.47

Crystal structure of the yeast TFIIA/TBP/DNA complex. Science (1996) 3.45

Mot1, a global repressor of RNA polymerase II transcription, inhibits TBP binding to DNA by an ATP-dependent mechanism. Genes Dev (1994) 3.45

The T cell receptor beta chain genes are located on chromosome 6 in mice and chromosome 7 in humans. Cell (1984) 3.34

Schistosomiasis and neglected tropical diseases: towards integrated and sustainable control and a word of caution. Parasitology (2009) 3.27

The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol (1999) 3.22

The identification of the mot gene product with Escherichia coli-lambda hybrids. Proc Natl Acad Sci U S A (1976) 3.20

Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system. Blood (1996) 3.13

The influence of sampling effort and the performance of the Kato-Katz technique in diagnosing Schistosoma mansoni and hookworm co-infections in rural Côte d'Ivoire. Parasitology (2003) 3.11

Synthesis of mot and che gene products of Escherichia coli programmed by hybrid ColE1 plasmids in minicells. J Bacteriol (1977) 3.05

Mitochondrial splicing requires a protein from a novel helicase family. Nature (1989) 3.03

Phase variation in Salmonella: genetic analysis of a recombinational switch. Proc Natl Acad Sci U S A (1979) 3.02

The use of unequal randomisation ratios in clinical trials: a review. Contemp Clin Trials (2005) 2.98

Regulation of gene expression by site-specific inversion. Cell (1978) 2.97

Phase variation: evolution of a controlling element. Science (1980) 2.96

Intermediates in formation and activity of the RNA polymerase II preinitiation complex: holoenzyme recruitment and a postrecruitment role for the TATA box and TFIIB. Genes Dev (1999) 2.94

An estimation of the entomological inoculation rate for Ifakara: a semi-urban area in a region of intense malaria transmission in Tanzania. Trop Med Int Health (2003) 2.94

Purification and thermal stability of intact Bacillus subtilis flagella. J Bacteriol (1971) 2.87

Association of mitochondria with microtubules in cultured cells. Proc Natl Acad Sci U S A (1978) 2.85

The nature and significance of platelet products in human plasma. Br J Haematol (1967) 2.84

A yeast and a human CCAAT-binding protein have heterologous subunits that are functionally interchangeable. Cell (1988) 2.84

Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma. Proc Natl Acad Sci U S A (1998) 2.80

Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Xeroderma Pigmentosum Study Group. Lancet (2001) 2.79

Resistance to adriamycin in multicellular spheroids. Int J Radiat Oncol Biol Phys (1979) 2.78

Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins. Mol Biochem Parasitol (1997) 2.77

Variants of the TATA-binding protein can distinguish subsets of RNA polymerase I, II, and III promoters. Cell (1992) 2.76

Bacterial chemotaxis. Annu Rev Physiol (1982) 2.74

Yeast HAP2 and HAP3 activators both bind to the CYC1 upstream activation site, UAS2, in an interdependent manner. Cell (1987) 2.73

KINET: a social marketing programme of treated nets and net treatment for malaria control in Tanzania, with evaluation of child health and long-term survival. Trans R Soc Trop Med Hyg (1999) 2.73

The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. Genes Dev (1998) 2.72

Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. Mol Cell (2000) 2.70

The role of the TATA-binding protein in the assembly and function of the multisubunit yeast RNA polymerase III transcription factor, TFIIIB. Cell (1992) 2.69

Noninvasive in vivo detection and quantification of Demodex mites by confocal laser scanning microscopy. Br J Dermatol (2012) 2.67

Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis. J Immunol (2000) 2.66

Polymerization of Ftsz, a bacterial homolog of tubulin. is assembly cooperative? J Biol Chem (2001) 2.62

Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival. J Clin Oncol (2001) 2.58

[Letter: Idiopathic hemochromatosis associated with HL-A 3 tissular antigen]. Nouv Presse Med (1975) 2.57

Health seeking and perceived causes of tuberculosis among patients in Manila, Philippines. Trop Med Int Health (2000) 2.56

The engrailed locus of Drosophila: in situ localization of transcripts reveals compartment-specific expression. Cell (1985) 2.55

Age dependence of the multiplicity of Plasmodium falciparum infections and of other malariological indices in an area of high endemicity. Trans R Soc Trop Med Hyg (1999) 2.51

Cloning and expression of the flagellar hook gene on hybird plasmids in minicells. Nature (1977) 2.50

From "one medicine" to "one health" and systemic approaches to health and well-being. Prev Vet Med (2010) 2.49

Recruitment of the SWI/SNF chromatin remodeling complex by transcriptional activators. Genes Dev (1999) 2.48

Genes for the hook-basal body proteins of the flagellar apparatus in Escherichia coli. J Bacteriol (1978) 2.44

Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity. J Immunol (1994) 2.41

The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome. Addiction (1998) 2.41

Spatial risk prediction and mapping of Schistosoma mansoni infections among schoolchildren living in western Côte d'Ivoire. Parasitology (2005) 2.41

European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications - actinic keratoses, Bowen's disease, basal cell carcinoma. J Eur Acad Dermatol Venereol (2012) 2.41

The KIN28 gene is required both for RNA polymerase II mediated transcription and phosphorylation of the Rpb1p CTD. J Mol Biol (1995) 2.38

Bacterial bioluminescence: isolation and expression of the luciferase genes from Vibrio harveyi. Science (1982) 2.38

The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J Clin Invest (1995) 2.37

Characterization of lambda Escherichia coli hybrids carrying chemotaxis genes. J Bacteriol (1977) 2.37

Premunition in Plasmodium falciparum infection: insights from the epidemiology of multiple infections. Trans R Soc Trop Med Hyg (1999) 2.35

Relative contribution of day-to-day and intra-specimen variation in faecal egg counts of Schistosoma mansoni before and after treatment with praziquantel. Parasitology (2001) 2.34

Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway. Cell (1996) 2.32

Extent of misclassification of death from Creutzfeldt-Jakob disease in England 1979-96: retrospective examination of clinical records. BMJ (2000) 2.32

Mapping the densities of malaria vectors within a single village. Acta Trop (1995) 2.31

DNA sequence adjacent to flagellar genes and evolution of flagellar-phase variation. J Bacteriol (1983) 2.30

Transposon mutagenesis of marine Vibrio spp. J Bacteriol (1984) 2.29

Ultraviolet light depletes surface markers of Langerhans cells. J Invest Dermatol (1981) 2.28

Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J Clin Chem Clin Biochem (1984) 2.25

RED: a red-cell antibody identification expert module. J Med Syst (1985) 2.24